Pyrotinib/Capecitabine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pyrotinib/Capecitabine, covering 2026-02-18 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study [Phase 2]